Drs. Gunda Georg & Vadim Gurvich - Minnelide research

| No Comments

The October 17 issue of Science Translational Medicine features the latest results of Institute for Therapeutics Discovery & Development faculty in the article "A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer." ITDD directors Gunda Georg and Vadim Gurvich are working with other University of Minnesota researchers to develop Minnelide, a new drug to treat pancreatic cancer.

Leave a comment

About this Entry

This page contains a single entry by johns169 published on October 17, 2012 4:22 PM.

Dr. Chengguo Xing - HealthTalk story was the previous entry in this blog.

Dr. Gunda Georg - UO1 Grant is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.